Everbright Health raises $7M seed funding from W Health Ventures, Sanos Capital

Everbright Health, a managed services platform for mental health providers, has raised $7 million in seed funding from W Health Ventures and Sanos Capital. The company aims to help psychiatrists, psychologists, and therapists deliver advanced interventions such as Transcranial Magnetic Stimulation (TMS) alongside traditional therapy and medication.

Everbright’s platform combines proprietary technology with an AI-powered operations team split between the US and India. The system supports mental health practices in identifying eligible patients, managing prior authorisations, and handling compliance, treatment delivery, and revenue cycle management.

“Millions of patients don’t achieve full recovery through talk therapy or medication alone,” said Ben Kuhn, Co-founder and CEO of Everbright Health, in a statement. “We’re building a future where every mental health provider can deliver a full spectrum of care.”

The company allows clinicians to integrate advanced treatments without building costly infrastructure. “We’re bullish on the asset-light management services model because it enables true partnerships with clinicians,” said Dr Pankaj Jethwani, Managing Partner at W Health Ventures. “With remarkable outcomes and growing demand, these treatments are on the cusp of becoming mainstream, poised for their own ‘GLP-1 moment’ of adoption.”

Within three months of launch, Everbright said it had signed contracts with more than 75 behavioural health providers across seven US markets. The company plans to use the new funding to expand its technology platform, accelerate its US rollout, and introduce new therapy areas using similar operational models.

Everbright Health is a division of Careforce Inc. The company’s India-based team handles clinical operations, technology development, and workflow optimisation.